Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. in a Debt Facility for up to $10,000,000
Press Release – New York, NY – January 21, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented MabVax Therapeutics Holdings, Inc. in connection with a debt facility for up to $10,000,000 of which the Company has received $5,000,000. The company focuses on developing vaccine antibody-based therapeutics for the diagnosis and treatment of cancer. The Sichenzia Ross Friedman Ference LLP team was led by Harvey Kesner, David Manno and Tara Guarneri-Ferrara.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Medical Marijuana Dispensary Business Project 1493, LLC Announces Share Exchange Agreement with Public Entity & Simultaneous $3.3 Million PIPE Financing - June 16, 2017
- Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing - June 15, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc. - June 8, 2017